Thu, Jan 29, 2015, 12:02 AM EST - U.S. Markets open in 9 hrs 28 mins

Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • em438@rocketmail.com em438 Jul 11, 2013 6:10 PM Flag

    Cempra liver toxicity

    One patient in the solithromycin group experienced a grade 3 elevation in the liver enzyme ALT but the patient also had hepatitis C and entered the study with ALT enzymes already moderately elevated. In addition, there were two cases of temporary elevations of AST in the solithromycin group but neither had concomitant increase in bilirubin -- a more serious signal of liver toxicity....What ever...talking it down doesn't change the obvious.
    This was well controlled hand picked group of patient's and there was still liver toxicity...Just wait until it hits general population when approved, Ketek looked ok in clinical trials too. Then this Liver hand grenade was thrown into the general population and people died. Just give me Tedizolid thank you.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
TSRX
13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Exelixis, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
QUALCOMM Incorporated
NASDAQWed, Jan 28, 2015 4:00 PM EST